{"count": 20, "results": [{"_id": "32801130", "pmid": 32801130, "pmcid": "PMC7510037", "title": "Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study", "journal": "Diabetes Care", "authors": ["Donnelly LA", "Dennis JM", "Coleman RL", "Sattar N", "Hattersley AT", "Holman RR", "Pearson ER"], "date": "2020-10-01T00:00:00Z", "doi": "10.2337/dc20-1104", "meta_date_publication": "2020 Oct", "meta_volume": "43", "meta_issue": "10", "meta_pages": "2493-2499", "score": 50281.01, "text_hl": "Risk of @<m>DISEASE_Anemia</m> @DISEASE_MESH:D000740 @@@Anemia@@@ With @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Use in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@: A MASTERMIND Study", "citations": {"NLM": "Donnelly LA, Dennis JM, Coleman RL, Sattar N, Hattersley AT, Holman RR, Pearson ER. Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study Diabetes Care. 2020 Oct;43(10):2493-2499. PMID: 32801130", "BibTeX": "@article{32801130, title={Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study}, author={Donnelly LA and Dennis JM and Coleman RL and Sattar N and Hattersley AT and Holman RR and Pearson ER}, journal={Diabetes Care}, volume={43}, number={10}, pages={2493-2499}}"}}, {"_id": "34510471", "pmid": 34510471, "title": "Metformin and the Risk of Anemia of Advanced Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus.", "journal": "J Clin Pharmacol", "authors": ["Wu CT", "Tsai YT", "Jung HK", "Fu SL", "Hsiung CA", "Liu HY", "Lai JN"], "date": "2022-02-01T00:00:00Z", "doi": "10.1002/jcph.1965", "meta_date_publication": "2022 Feb", "meta_volume": "62", "meta_issue": "2", "meta_pages": "276-284", "score": 50256.75, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and the Risk of @<m>DISEASE_Anemia</m> @DISEASE_MESH:D000740 @@@Anemia@@@ of Advanced @DISEASE_Renal_Insufficiency_Chronic @DISEASE_MESH:D051436 @@@Chronic Kidney Disease@@@ in @SPECIES_9606 @@@Patients@@@ With @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes Mellitus@@@.", "citations": {"NLM": "Wu CT, Tsai YT, Jung HK, Fu SL, Hsiung CA, Liu HY, Lai JN. Metformin and the Risk of Anemia of Advanced Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus. J Clin Pharmacol. 2022 Feb;62(2):276-284. PMID: 34510471", "BibTeX": "@article{34510471, title={Metformin and the Risk of Anemia of Advanced Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus.}, author={Wu CT and Tsai YT and Jung HK and Fu SL and Hsiung CA and Liu HY and Lai JN}, journal={J Clin Pharmacol}, volume={62}, number={2}, pages={276-284}}"}}, {"_id": "33116733", "pmid": 33116733, "pmcid": "PMC7586010", "title": "Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus", "journal": "Diabetes Metab Syndr Obes", "authors": ["Albai O", "Timar B", "Paun DL", "Sima A", "Roman D", "Timar R"], "date": "2020-10-21T00:00:00Z", "doi": "10.2147/DMSO.S270393", "meta_date_publication": "2020", "meta_volume": "13", "meta_issue": "", "meta_pages": "3873-3878", "score": 50252.414, "text_hl": "Periodical dosing of @CHEMICAL_Vitamin_B_12 @CHEMICAL_MESH:D014805 @@@vitamin B12@@@ should be performed in the case of @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes Mellitus@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, especially if they associate @<m>DISEASE_Anemia</m> @DISEASE_MESH:D000740 @@@anemia@@@ and/or @DISEASE_Diabetic_Neuropathies @DISEASE_MESH:D003929 @@@peripheral diabetic polyneuropathy@@@.", "citations": {"NLM": "Albai O, Timar B, Paun DL, Sima A, Roman D, Timar R. Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus Diabetes Metab Syndr Obes. 2020;13():3873-3878. PMID: 33116733", "BibTeX": "@article{33116733, title={Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus}, author={Albai O and Timar B and Paun DL and Sima A and Roman D and Timar R}, journal={Diabetes Metab Syndr Obes}, volume={13}, pages={3873-3878}}"}}, {"_id": "31868971", "pmid": 31868971, "pmcid": "PMC7378433", "title": "Relationship between metformin use and vitamin B12 status in patients with type 2 diabetes in Japan", "journal": "J Diabetes Investig", "authors": ["Sugawara K", "Okada Y", "Hirota Y", "Sakaguchi K", "Ogawa W"], "date": "2020-07-01T00:00:00Z", "doi": "10.1111/jdi.13200", "meta_date_publication": "2020 Jul", "meta_volume": "11", "meta_issue": "4", "meta_pages": "917-922", "score": 50246.492, "text_hl": "However, high doses of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ might result in a moderate decrease in the circulating @CHEMICAL_Vitamin_B_12 @CHEMICAL_MESH:D014805 @@@VB12@@@ level, as well as in @<m>DISEASE_Anemia</m> @DISEASE_MESH:D000740 @@@anemia@@@ in elderly individuals.", "citations": {"NLM": "Sugawara K, Okada Y, Hirota Y, Sakaguchi K, Ogawa W. Relationship between metformin use and vitamin B12 status in patients with type 2 diabetes in Japan J Diabetes Investig. 2020 Jul;11(4):917-922. PMID: 31868971", "BibTeX": "@article{31868971, title={Relationship between metformin use and vitamin B12 status in patients with type 2 diabetes in Japan}, author={Sugawara K and Okada Y and Hirota Y and Sakaguchi K and Ogawa W}, journal={J Diabetes Investig}, volume={11}, number={4}, pages={917-922}}"}}, {"_id": "39787747", "pmid": 39787747, "title": "A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.", "journal": "Gynecol Oncol", "authors": ["Ahmed J", "Stephen B", "Khawaja MR", "Yang Y", "Salih I", "Barrientos-Toro E", "Raso MG", "Karp DD", "Piha-Paul SA", "Sood AK", "Ng CS", "Johnson A", "Soliman PT", "Meric-Bernstam F", "Lu KH", "Naing A"], "date": "2025-01-08T00:00:00Z", "doi": "10.1016/j.ygyno.2024.12.019", "meta_date_publication": "2025 Jan 8", "meta_volume": "193", "meta_issue": "", "meta_pages": "73-80", "score": 50246.48, "text_hl": "In addition to inducing metabolic changes in cells, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ activates @GENE_PRKAA2 @GENE_5563 @@@AMPK@@@, which in turn inhibits the @GENE_MTOR @GENE_2475 @@@mTOR@@@ pathway. ", "citations": {"NLM": "Ahmed J, Stephen B, Khawaja MR, Yang Y, Salih I, Barrientos-Toro E, Raso MG, Karp DD, Piha-Paul SA, Sood AK, Ng CS, Johnson A, Soliman PT, Meric-Bernstam F, Lu KH, Naing A. A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer. Gynecol Oncol. 2025 Jan 8;193():73-80. PMID: 39787747", "BibTeX": "@article{39787747, title={A phase I study of temsirolimus in combination with metformin in patients with advanced or recurrent endometrial cancer.}, author={Ahmed J and Stephen B and Khawaja MR and Yang Y and Salih I and Barrientos-Toro E and Raso MG and Karp DD and Piha-Paul SA and Sood AK and Ng CS and Johnson A and Soliman PT and Meric-Bernstam F and Lu KH and Naing A}, journal={Gynecol Oncol}, volume={193}, pages={73-80}}"}}, {"_id": "34806449", "pmid": 34806449, "title": "Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.", "journal": "Am J Physiol Renal Physiol", "authors": ["Pastor-Soler NM", "Li H", "Pham J", "Rivera D", "Ho PY", "Mancino V", "Saitta B", "Hallows KR"], "date": "2022-01-01T00:00:00Z", "doi": "10.1152/ajprenal.00298.2021", "meta_date_publication": "2022 Jan 1", "meta_volume": "322", "meta_issue": "1", "meta_pages": "F27-F41", "score": 50245.375, "text_hl": "Relative to controls, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduced kidney weight/body weight, cystic index and BUN levels, while improving GFR, blood pressure and @<m>DISEASE_Anemia</m> @DISEASE_MESH:D000740 @@@anemia@@@. ", "citations": {"NLM": "Pastor-Soler NM, Li H, Pham J, Rivera D, Ho PY, Mancino V, Saitta B, Hallows KR. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model. Am J Physiol Renal Physiol. 2022 Jan 1;322(1):F27-F41. PMID: 34806449", "BibTeX": "@article{34806449, title={Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.}, author={Pastor-Soler NM and Li H and Pham J and Rivera D and Ho PY and Mancino V and Saitta B and Hallows KR}, journal={Am J Physiol Renal Physiol}, volume={322}, number={1}, pages={F27-F41}}"}}, {"_id": "31955662", "pmid": 31955662, "title": "Evaluation of Vitamin B12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy.", "journal": "J Pharm Pract", "authors": ["Runeberg HA", "Higbea AM", "Weideman RA", "Alvarez CA"], "date": "2021-10-01T00:00:00Z", "doi": "10.1177/0897190019899260", "meta_date_publication": "2021 Oct", "meta_volume": "34", "meta_issue": "5", "meta_pages": "715-720", "score": 50244.523, "text_hl": "Since 2017, the American @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Association (ADA) Standards of Medical Care in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Guideline has included a recommendation for periodic @CHEMICAL_Vitamin_B_12 @CHEMICAL_MESH:D014805 @@@vitamin B12@@@ measurements in @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated @SPECIES_9606 @@@patients@@@, especially those with @<m>DISEASE_Anemia</m> @DISEASE_MESH:D000740 @@@anemia@@@ or @DISEASE_Peripheral_Nervous_System_Diseases @DISEASE_MESH:D010523 @@@peripheral neuropathy@@@. ", "citations": {"NLM": "Runeberg HA, Higbea AM, Weideman RA, Alvarez CA. Evaluation of Vitamin B12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy. J Pharm Pract. 2021 Oct;34(5):715-720. PMID: 31955662", "BibTeX": "@article{31955662, title={Evaluation of Vitamin B12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy.}, author={Runeberg HA and Higbea AM and Weideman RA and Alvarez CA}, journal={J Pharm Pract}, volume={34}, number={5}, pages={715-720}}"}}, {"_id": "37689151", "pmid": 37689151, "title": "Health impact assessment after Danio rerio long-term exposure to environmentally relevant concentrations of metformin and guanylurea.", "journal": "Chemosphere", "authors": ["Elizalde-Velázquez GA", "Herrera-Vázquez SE", "Gómez-Oliván LM", "García-Medina S"], "date": "2023-09-07T00:00:00Z", "doi": "10.1016/j.chemosphere.2023.140070", "meta_date_publication": "2023 Sep 7", "meta_volume": "341", "meta_issue": "", "meta_pages": "140070", "score": 50243.004, "text_hl": "The observed biochemical changes indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@ and @CHEMICAL_guanidine_carboxamide @CHEMICAL_MESH:C029280 @@@GUA@@@ are responsible for inducing @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@hepatic damage@@@ in fish, whereas hematological alterations suggest that both compounds cause @<m>DISEASE_Anemia</m> @DISEASE_MESH:D000740 @@@anemia@@@. ", "citations": {"NLM": "Elizalde-Velázquez GA, Herrera-Vázquez SE, Gómez-Oliván LM, García-Medina S. Health impact assessment after Danio rerio long-term exposure to environmentally relevant concentrations of metformin and guanylurea. Chemosphere. 2023 Sep 7;341():140070. PMID: 37689151", "BibTeX": "@article{37689151, title={Health impact assessment after Danio rerio long-term exposure to environmentally relevant concentrations of metformin and guanylurea.}, author={Elizalde-Velázquez GA and Herrera-Vázquez SE and Gómez-Oliván LM and García-Medina S}, journal={Chemosphere}, volume={341}, pages={140070}}"}}, {"_id": "36247416", "pmid": 36247416, "pmcid": "PMC9556255", "title": "Metformin-Associated Lactic Acidosis in a Diabetic Patient with Normal Kidney Function and Occult Cirrhosis", "journal": "Case Rep Crit Care", "authors": ["Chidiac J", "Kassab R", "Iskandar M", "Koubar S", "Aoun M"], "date": "2022-10-05T00:00:00Z", "doi": "10.1155/2022/5506744", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "5506744", "score": 50241.227, "text_hl": "High doses of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ are defined as >5 g/day in adults. ", "citations": {"NLM": "Chidiac J, Kassab R, Iskandar M, Koubar S, Aoun M. Metformin-Associated Lactic Acidosis in a Diabetic Patient with Normal Kidney Function and Occult Cirrhosis Case Rep Crit Care. 2022;2022():5506744. PMID: 36247416", "BibTeX": "@article{36247416, title={Metformin-Associated Lactic Acidosis in a Diabetic Patient with Normal Kidney Function and Occult Cirrhosis}, author={Chidiac J and Kassab R and Iskandar M and Koubar S and Aoun M}, journal={Case Rep Crit Care}, volume={2022}, pages={5506744}}"}}, {"_id": "32146550", "pmid": 32146550, "pmcid": "PMC7497683", "title": "Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer", "journal": "Invest New Drugs", "authors": ["Broekman KE", "Hof MAJ", "Touw DJ", "Gietema JA", "Nijman HW", "Lefrandt JD", "Reyners AKL", "Jalving M"], "date": "2020-10-01T00:00:00Z", "doi": "10.1007/s10637-020-00920-7", "meta_date_publication": "2020 Oct", "meta_volume": "38", "meta_issue": "5", "meta_pages": "1454-1462", "score": 50239.09, "text_hl": "No DLTs were observed for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Six @SPECIES_9606 @@@patients@@@ were treated at the 1000 mg tds @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose level. ", "citations": {"NLM": "Broekman KE, Hof MAJ, Touw DJ, Gietema JA, Nijman HW, Lefrandt JD, Reyners AKL, Jalving M. Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer Invest New Drugs. 2020 Oct;38(5):1454-1462. PMID: 32146550", "BibTeX": "@article{32146550, title={Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer}, author={Broekman KE and Hof MAJ and Touw DJ and Gietema JA and Nijman HW and Lefrandt JD and Reyners AKL and Jalving M}, journal={Invest New Drugs}, volume={38}, number={5}, pages={1454-1462}}"}}]}